We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

110 hedge funds and large institutions have $508M invested in Keryx Biopharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

84% more call options, than puts

Call options by funds: $31.3M | Put options by funds: $17M

30% more capital invested

Capital invested by funds: $390M → $508M (+$118M)

14% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 37

8% more funds holding

Funds holding: 102 → 110 (+8)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
110
Holders Change
+8
Holders Change %
+7.84%
% of All Funds
3.57%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
16
Increased
42
Reduced
37
Closed
7
Calls
$31.3M
Puts
$17M
Net Calls
+$14.3M
Net Calls Change
+$27.6M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$11.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$10.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$8.82M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.3M
5
HCM
Harvey Capital Management
Florida
+$7.3M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$29.1M
2
DM
Deerfield Management
New York
-$17.9M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$10.5M
4
BA
BlackRock Advisors
Delaware
-$8.84M
5
Millennium Management
Millennium Management
New York
-$6.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$4.92M +$4.33M +486,900 New
Principal Financial Group
27
Principal Financial Group
Iowa
$4.13M -$15.7K -1,761 -0.4%
Millennium Management
28
Millennium Management
New York
$3.84M -$6.55M -735,651 -66%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.54M +$108K +12,108 +4%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$3.39M +$1.23M +137,877 +70%
TCIM
31
TIAA CREF Investment Management
New York
$3.31M -$131K -14,713 -4%
GC
32
Guggenheim Capital
Illinois
$2.88M +$391K +43,888 +18%
HPA
33
Hilltop Park Associates
New York
$2.6M +$1.78M +200,000 +400%
EI
34
EAM Investors
California
$2.34M -$99.9K -11,230 -5%
BIM
35
BlackRock Investment Management
Delaware
$2.33M +$111K +12,419 +6%
Group One Trading
36
Group One Trading
Illinois
$2.3M -$522K -58,694 -21%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$2.08M +$285K +32,000 +18%
WC
38
Wexford Capital
Florida
$2.04M +$1.8M +201,960 New
PA
39
Perceptive Advisors
New York
$2.02M +$1.33M +150,000 +300%
ARTA
40
A.R.T. Advisors
New York
$1.88M +$360K +40,451 +28%
Allianz Asset Management
41
Allianz Asset Management
Germany
$1.86M +$1.64M +183,880 New
RFC
42
Russell Frank Company
Washington
$1.83M -$230K -25,877 -13%
Charles Schwab
43
Charles Schwab
California
$1.81M +$46K +5,168 +3%
CS
44
Credit Suisse
Switzerland
$1.68M +$1.09M +121,952 +272%
AllianceBernstein
45
AllianceBernstein
Tennessee
$1.51M +$18 +2 +0%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.51M +$1.3M +145,800 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.49M +$41.3K +4,639 +3%
PC
48
Pier Capital
Connecticut
$1.42M -$2.44M -274,116 -66%
Morgan Stanley
49
Morgan Stanley
New York
$1.26M -$92.7K -10,421 -8%
PCM
50
Prelude Capital Management
New York
$1.26M – – –
1
2
3 4 5

KERX Hedge Fund Activity: Q3 2013 in Review

110 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q3 2013, worth a combined $508M — up 30% from $390M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KERX positions and 7 closed out — a net gain of 9 holders — while 42 added to existing stakes and 37 trimmed.

The largest buyer was Ameriprise, adding an estimated $11.7M. The largest seller was RA Capital Management, cutting an estimated $29.1M.

  • 110 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q3 2013, up from 102 in Q2 2013.
  • Funds reported $508M of Keryx Biopharmaceuticals Inc stock for Q3 2013, up 30% quarter-over-quarter.
  • 16 funds opened new Keryx Biopharmaceuticals Inc positions in Q3 2013 and 7 closed out, a net change of +9 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q3 2013 was Ameriprise, an estimated $11.7M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q3 2013 was RA Capital Management, an estimated $29.1M sold.

Based on aggregated 13F filings for Q3 2013.